N-methyl-d-aspartate antagonists as drug models of schizophrenia: a surprising link to tobacco smoking-Reference-Cited by-同舟云学术

N-methyl-d-aspartate antagonists as drug models of schizophrenia: a surprising link to tobacco smoking

Published:2004-08 Issue:5 Volume:28 Page:801-811
ISSN:0278-5846
Container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry
language:en
Short-container-title:Progress in Neuro-Psychopharmacology and Biological Psychiatry

Author:

Domino Edward F.,Mirzoyan Diana,Tsukada Hideo

Publisher

Elsevier BV

Subject

Biological Psychiatry,Pharmacology

Reference141 articles.

1. Prefrontal dopamine D1 receptors and working memory in schizophrenia;Abi-Dargham;J. Neurosci,2002

2. PET imaging of prefrontal dopamine D1 receptors in chronic PCP/ketamine human abusers: a model for schizophrenia;Abi-Dargham;Sci. Abstr., Am. Coll. Neuropsychopharmacol,2003

3. The NMDA antagonist model for schizophrenia: promise and pitfalls;Abi-Saab;Pharmacopsychiatry,1998

4. Psychedelic drugs;Abraham,2002

5. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia;Adler;Biol. Psychiatry,1982

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulation of mGlu5 improves sensorimotor gating deficits in rats neonatally treated with quinpirole through changes in dopamine D2 signaling;Pharmacology Biochemistry and Behavior;2021-12

Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment

;Neuropsychiatric Disease and Treatment;2020-02

Nicotine consumption during the prodromal phase of schizophrenia – a review of the literature

;Neuropsychiatric Disease and Treatment;2019-10

4. Conclusions;BioInformation Processing;2016

5. Drug models of schizophrenia;Therapeutic Advances in Psychopharmacology;2014-11-09